Something strange has been happening with biotech stocks over the past few weeks: They have been going up. The SPDR S&P Biotech ETF, a benchmark for the sector, closed April 8 at $69.80, its worst ...

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat ...

SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today reported its first quarter 2024 unaudited financial results and key ...

The volatile biotech industry has put up a strong performance in 2025 despite the uncertain macroeconomic environment. While ...

Jyong Biotech (NasdaqGM:MENS) has seen some interesting moves in recent sessions, with the stock climbing about 12% yesterday despite no headline news driving the action. Investors appear to be ...

The biotech sector has been surging in recent months, reawakening from a period of underperformance that followed the 2021 highs. "I look for wherever I can make the most amount of money, legally, ...

SPDR® S&P Biotech ETF is a well-diversified, low-cost ETF that can be an excellent tool to capitalize on the potential of the biotech stock sector. XBI's performance should be compared with the ...

From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Philadelphia’s biotechnology industry is facing a wave of uncertainty, as several ...

SANTA ANA, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization ...

The following medical device manufacturer and biotech mergers occurred in the past two months. 1. In two days, Minneapolis-based Medtronic announced two acquisition deals. In the first deal, Medtronic ...